SEARCH RESULTS FOR: "Tag: NTLA"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(1)
2018(2)
2016(1)
CATEGORIES
Analyst Update(2)
Stocks On the Move(2)

2/8/2019 11:27 AM
BTIG is chiming in on healthcare names today, and for gene editing stocks Editas Medicine Inc (NASDAQ:EDIT) and Intellia Therapeutics Inc (NASDAQ:NTLA), this resulted in fresh "buy" ratings and impr...
7/16/2018 2:28 PM
U.S. stocks are sluggish today, as lower oil prices weigh on the major indexes. One group in particular that's under pressure is gene editing stocks, following another concerning study on CRISP/Ca...
1/8/2018 3:07 PM
It's another record-setting day on Wall Street, with the Dow, S&P 500 Index (SPX), and Nasdaq Composite (IXIC) fresh off all-time peaks. While the major market indexes are trading in a tight range, h...
5/31/2016 2:58 PM
Analysts are weighing in on stem cell research stock StemCells Inc (NASDAQ:STEM), genome editing specialist Intellia Therapeutics Inc (NASDAQ:NTLA), and visual computing firm NVIDIA Corporation (NASDA...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center